JP2020526190A5 - - Google Patents

Download PDF

Info

Publication number
JP2020526190A5
JP2020526190A5 JP2019572175A JP2019572175A JP2020526190A5 JP 2020526190 A5 JP2020526190 A5 JP 2020526190A5 JP 2019572175 A JP2019572175 A JP 2019572175A JP 2019572175 A JP2019572175 A JP 2019572175A JP 2020526190 A5 JP2020526190 A5 JP 2020526190A5
Authority
JP
Japan
Prior art keywords
column eluate
column
vector particles
lysate
raav vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019572175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020526190A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/040430 external-priority patent/WO2019006390A1/en
Publication of JP2020526190A publication Critical patent/JP2020526190A/ja
Publication of JP2020526190A5 publication Critical patent/JP2020526190A5/ja
Priority to JP2022177960A priority Critical patent/JP2023029832A/ja
Priority to JP2024211621A priority patent/JP2025038906A/ja
Pending legal-status Critical Current

Links

JP2019572175A 2017-06-30 2018-06-29 Aavベクターのカラム精製方法 Pending JP2020526190A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022177960A JP2023029832A (ja) 2017-06-30 2022-11-07 Aavベクターのカラム精製方法
JP2024211621A JP2025038906A (ja) 2017-06-30 2024-12-04 Aavベクターのカラム精製方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762527633P 2017-06-30 2017-06-30
US62/527,633 2017-06-30
US201762531744P 2017-07-12 2017-07-12
US62/531,744 2017-07-12
US201762567905P 2017-10-04 2017-10-04
US62/567,905 2017-10-04
PCT/US2018/040430 WO2019006390A1 (en) 2017-06-30 2018-06-29 AAV VECTOR COLUMN PURIFICATION METHOD

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022177960A Division JP2023029832A (ja) 2017-06-30 2022-11-07 Aavベクターのカラム精製方法

Publications (2)

Publication Number Publication Date
JP2020526190A JP2020526190A (ja) 2020-08-31
JP2020526190A5 true JP2020526190A5 (enExample) 2021-07-26

Family

ID=64742749

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019572175A Pending JP2020526190A (ja) 2017-06-30 2018-06-29 Aavベクターのカラム精製方法
JP2022177960A Pending JP2023029832A (ja) 2017-06-30 2022-11-07 Aavベクターのカラム精製方法
JP2024211621A Pending JP2025038906A (ja) 2017-06-30 2024-12-04 Aavベクターのカラム精製方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022177960A Pending JP2023029832A (ja) 2017-06-30 2022-11-07 Aavベクターのカラム精製方法
JP2024211621A Pending JP2025038906A (ja) 2017-06-30 2024-12-04 Aavベクターのカラム精製方法

Country Status (16)

Country Link
US (1) US20210079422A1 (enExample)
EP (1) EP3658250A4 (enExample)
JP (3) JP2020526190A (enExample)
KR (2) KR102669561B1 (enExample)
CN (1) CN111032176A (enExample)
AU (1) AU2018291023B2 (enExample)
CA (1) CA3068622A1 (enExample)
CL (1) CL2019003915A1 (enExample)
CO (1) CO2020000911A2 (enExample)
IL (1) IL271745A (enExample)
MX (2) MX2020000216A (enExample)
MY (1) MY207534A (enExample)
PE (2) PE20251545A1 (enExample)
PH (1) PH12020500044A1 (enExample)
SG (1) SG11201913157RA (enExample)
WO (1) WO2019006390A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016004113A1 (en) 2014-06-30 2016-01-07 Biogen Ma Inc. Optimized factor ix gene
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
US12565645B2 (en) * 2019-04-11 2026-03-03 Regenxbio Inc. Methods of size exclusion chromatography for the characterization of recombinant adeno-associated virus compositions
US12403164B2 (en) 2019-09-30 2025-09-02 Bioverativ Therapeutics Inc. Lentiviral vector formulations
AU2021262609A1 (en) 2020-05-01 2022-12-22 Kashiv Biosciences, Llc An improved process of purification of protein
EP3919613B1 (en) * 2020-06-05 2024-08-07 Sartorius BIA Separations d.o.o. Enhanced purification of adeno-associated virus to more effectively remove contaminating dna
KR20230074703A (ko) * 2020-06-24 2023-05-31 바이오버라티브 테라퓨틱스 인크. 유리 인자 viii을 상기 단백질이 발현되도록 변형된 렌티바이러스 벡터의 제제로부터 제거하는 방법
US20220033782A1 (en) * 2020-07-29 2022-02-03 Pall Corporation Adenovirus-associated viruses separation method
EP4229204A1 (en) 2020-10-15 2023-08-23 F. Hoffmann-La Roche AG Nucleic acid constructs for simultaneous gene activation
KR20230085929A (ko) 2020-10-15 2023-06-14 에프. 호프만-라 로슈 아게 Va rna 전사를 위한 핵산 구조체
JP7767029B2 (ja) * 2021-05-28 2025-11-11 ダイセン・メンブレン・システムズ株式会社 細胞外小胞の分離精製方法
JP7716233B2 (ja) * 2021-05-28 2025-07-31 ダイセン・メンブレン・システムズ株式会社 微小有用物質の分離精製方法と分離精製装置
PE20240359A1 (es) * 2021-06-11 2024-02-27 Spark Therapeutics Inc Metodos de purificacion de columna vectorial aav
AU2022358612A1 (en) * 2021-09-28 2024-04-11 Kashiv Biosciences, Llc An improved process of purification of fusion protein
CN114250222A (zh) * 2021-12-08 2022-03-29 苏州博腾生物制药有限公司 一种从动物组织中提取aav dna的方法
GB202117844D0 (en) * 2021-12-09 2022-01-26 Oxford Biomedica Ltd Purification method
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法
WO2023198685A1 (en) 2022-04-13 2023-10-19 F. Hoffmann-La Roche Ag Method for determining aav genomes
CN119256220A (zh) 2022-05-23 2025-01-03 豪夫迈·罗氏有限公司 用于区分aav颗粒血清型和aav颗粒荷载状态的基于拉曼的方法
EP4532737A1 (en) 2022-06-03 2025-04-09 F. Hoffmann-La Roche AG Method for producing recombinant aav particles
KR20250036743A (ko) 2022-07-14 2025-03-14 에프. 호프만-라 로슈 아게 재조합 aav 입자를 생산하는 방법
JPWO2024024337A1 (enExample) * 2022-07-28 2024-02-01
EP4744752A1 (en) 2022-09-12 2026-05-20 Hoffmann La Roche METHOD FOR SEPARING SOLID AND EMPTY AAV PARTICLES
EP4385618A1 (en) 2022-12-16 2024-06-19 Chiral Technologies Europe SAS Composite material for bioseparations
IL322001A (en) 2023-02-07 2025-09-01 Hoffmann La Roche Method for detecting antibodies to anti-AAV particles
EP4683676A1 (en) 2023-03-21 2026-01-28 F. Hoffmann-La Roche AG Method for the production of recombinant aav particle preparations
KR20250172636A (ko) * 2023-04-12 2025-12-09 씨티바 바이오프로세스 알&디 에이비 크로마토그래피 시스템, 이의 용도, 및 아데노-연관 캡시드를 분리하는 방법
WO2025168663A1 (en) 2024-02-09 2025-08-14 F. Hoffmann-La Roche Ag Method for producing recombinant adeno-associated viral particles
TW202603164A (zh) * 2024-04-07 2026-01-16 美商星火治療公司 用於腺相關病毒殼體變異體純化之組成物及方法
WO2025252480A1 (en) 2024-06-07 2025-12-11 F. Hoffmann-La Roche Ag Method for purifying plasmid dna
WO2026022064A1 (en) 2024-07-22 2026-01-29 F. Hoffmann-La Roche Ag Novel aav rep orfs and rep polypeptides
WO2026037757A1 (en) 2024-08-13 2026-02-19 F. Hoffmann-La Roche Ag Modified aav particles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1944362T3 (en) * 1997-09-05 2016-01-25 Genzyme Corp Fremgangsmåder til fremstilling af hjælpevirusfri præparater med høj titer af rekombinante AAV-vektorer
US6593123B1 (en) * 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
US7261544B2 (en) * 2003-05-21 2007-08-28 Genzyme Corporation Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
KR101812813B1 (ko) * 2009-06-16 2017-12-27 젠자임 코포레이션 재조합 aav 벡터에 대한 개선된 정제 방법
ES2680915T3 (es) * 2010-01-28 2018-09-11 The Children's Hospital Of Philadelphia Plataforma de fabricación escalable para la purificación de vectores virales y vectores virales purificados de este modo para su utilización en terapia génica
MX2018006682A (es) * 2015-12-01 2018-09-26 Spark Therapeutics Inc Metodos escalables para producir vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspension libre de suero adecuado para su uso clinico.
US11015173B2 (en) * 2015-12-11 2021-05-25 The Trustees Of The University Of Pennsylvania Scalable purification method for AAV1
ES2918998T3 (es) * 2015-12-11 2022-07-21 Univ Pennsylvania Método de purificación escalable para AAVrh10
WO2017100676A1 (en) * 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav8
ES2896080T3 (es) * 2016-03-31 2022-02-23 Spark Therapeutics Inc Procedimiento en columna totalmente escalable de preparación de VAAr

Similar Documents

Publication Publication Date Title
JP2019509745A5 (enExample)
RU2018138164A (ru) ПОЛНОСТЬЮ МАСШТАБИРУЕМЫЙ СПОСОБ ПРОИЗВОДСТВА rAAV НА ОСНОВЕ КОЛОНОК
JP2018121653A5 (enExample)
KR102669561B1 (ko) Aav 벡터 컬럼 정제 방법
EP3256574B1 (en) Recombinant adeno-associated virus particle purification comprising an affinity purification step
US20250066743A1 (en) Methods and compositions for purifying adeno associated virus particles
WO2022261663A1 (en) Aav vector column purification methods
KR20250090298A (ko) Aav 캡시드를 정제하기 위한 크로마토그래피 방법
RU2772876C2 (ru) Колоночные способы очистки вектора на основе aav
WO2025027058A1 (en) Polishing for aav particles using anion exchange chromatography with improved elution system
BR112019028299B1 (pt) Método para a purificação de partículas de vetores adenoassociados recombinantes (raav)
WO2025226558A1 (en) Multi-step filtration and clarification methods for recombinant adeno-associated virus purification
HK40003857B (en) Column-based fully scalable raav manufacturing process
CN117794629A (zh) Aav载体的柱纯化方法